TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
Loading market information…
NEO · FH.NE · CAD
Stock price, earnings
Quote as of May 21, 2025, 07:22 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Filament Health Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Filament Health Corp. focuses on the discovery and advanced extraction of natural psychedelic compounds. The firm actively cultivates psychedelic flora, conducts genetic investigations, develops extraction methodologies, and performs internal clinical trials. It then supplies its intellectual property and potential pharmaceutical agents to drug developers, scientific researchers, and other authorized organizations. Its corporate headquarters are located in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Nov 10, 2022 |
| -CA$0.01+50.0% vs estimate |
| CA$32.00K |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
CA$33.53-CA$0.14 (-0.42%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.79% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
CA$0.12+CA$0.03 (+26.32%)
Refined Metals Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
THC Biomed Intl Ltd.’s quoted price sits in the lower half of its reported 52-week range, 95.92% below the high.
$0.00$0.00 (0.0%)
Body and Mind Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
